More than 15 million people across Europe have heart failure.1 Help them prevent hospitalizations and reduce mortality risk2 with the CardioMEMS™ HF System, the system that has demonstrated proven benefits in a variety of clinical studies, including four prospective trials studying more than 3,000 people3,4 and three large retrospective studies of more than 5,000 patients.5-7
The CardioMEMS HF System is the only remote monitoring platform for both HFpEF1 and HFrEF patients clinically proven to:
As telemedicine becomes more common, the CardioMEMS HF System is a safe, reliable way to help your patients manage their heart failure.
The CardioMEMS HF System offers you real-time notification of patient changes and simple, convenient access to secure data for proactive, personalized patient management. It also provides patients with a heightened awareness of the factors affecting their health and a powerful sense of control.
The CardioMEMS HF System promotes seamless, enhanced remote management for your patients. The system integrates a 3-month optimization phase4 that also delivers continuing substantial maintenance support. Intuitive remote monitoring and excellent patient adherence4 with the myCardioMEMS™ app clarifies and enhances patient-clinician communication to streamline the delivery of patient treatment.
The CardioMEMS™ PA Sensor is inserted via a commonly performed right heart catheterization, often as an outpatient procedure. Most patients can return home the same day, and then you’ll have precise and actionable presymptomatic data to inform proactive treatment modifications going forward.
The patient takes daily readings from wherever they are using the portable CardioMEMS™ Patient Electronics System, giving you a clear picture of their hemodynamic status.
Patient readings are uploaded remotely to the Merlin.net™ Patient Care Network (PCN), a secure website that easily presents PA pressure data. Based on customizable settings, you can identify patients needing attention, allowing you to intervene before a patient becomes symptomatic.
If intervention is necessary, you or your team will contact the patient to modify care. In addition to contacting patients via phone or text, the myCardioMEMS™ Mobile App can be used to send patients customizable messages about lifestyle or medication changes.
The CardioMEMS™ HF System enables you to provide enhanced, personalized patient care to enrich patients’ lives through the power of data. With the CardioMEMS™ HF System, you can offer a proven reduction of heart failure related hospitalization by up to 82%8, confirming the verified impact on patient outcomes.
The CardioMEMS™ HF System’s innovative technology can help transform your heart failure patients’ quality of life and provide increased safety in patient care and management.
In clinical studies, heart failure patients implanted with the CardioMEMS™ HF System showed an important improvement across all surveys (KCCQ, PHQ-9, EQ-5D-5L)4
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?